Lakefront Biotherapeutics | GLPG - Pasivo Circulante





Pasivo Circulante Cambio Fecha
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Biogen USD 3B 350.5M 2026-03
Genmab DKK 1.43B 686M 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
GRIFOLS EUR 2.12B 105M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Incyte USD 1.31B 177.55M 2026-06
Merck EUR 9.35B 307M 2026-03
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Novartis USD 31.75B 374M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 30.01B 1.66B 2026-03
UCB EUR 4.4B 470M 2025-12
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03